跳至主要内容
临床试验/NCT05888181
NCT05888181已完成不适用

Effectiveness and Feasibility of a Mobile Health Self-management Intervention for Patients With Rheumatoid Arthritis: the App-based Education and GOal-setting in Rheumatoid Arthritis Trial

Universitaire Ziekenhuizen KU Leuven4 个研究点 分布在 1 个国家目标入组 128 人开始时间: 2023年3月3日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
128
试验地点
4
主要终点
Arthritis Self-Efficacy Scale (ASES)

研究概览

简要总结

The purpose of this pragmatic, investigator-initiated, multicentre randomised controlled trial is to study the effectiveness and feasibility of a mobile app-based self-management intervention for patients with rheumatoid arthritis (RA), aiming to improve self-efficacy for the management of RA-related symptoms. The intervention consists of education, lifestyle advice and remote monitoring elements and is based on principles of goal setting, self-efficacy theory and behavioural economics, embedded within a platform supported by motivational features and gamification. The primary endpoint is defined as achieving at least a minimal clinically important difference in arthritis-related self-efficacy (the ASES-score) at the follow-up visit in favour of the intervention group when compared to the control group.

Moreover, although qualitative studies have highlighted concerns among both patients and healthcare professionals that mobile apps might induce illness behaviour by increasing patients' awareness of their symptoms, this has rarely been studied in detail. Consequently, data regarding the effects of remote monitoring on symptom hypervigilance remain limited and conflicting. Therefore, this trial additionally aims to assess (as a key secondary objective) if a mobile app-based intervention is associated with changes in pain catastrophising, as a conceptualisation of hypervigilance to symptoms.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Supportive Care
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • 未提供

排除标准

  • 未提供

结局指标

主要结局

Arthritis Self-Efficacy Scale (ASES)

时间窗: At follow-up visit (4-6 months from baseline)

Superiority outcome. The ASES is a patient-reported questionnaire consisting of 20 items across 2 subscales: self-efficacy for managing pain (range 5-50), and self-efficacy for controlling other symptoms (range 6-60). Both scores can be summed to derive a total ASES-score (range 11-110). Higher scores indicate higher perceived self-efficacy.

次要结局

  • Pain Catastrophizing Scale (PCS)(At follow-up visit (4-6 months from baseline))
  • Rheumatoid Arthritis Impact of Disease (RAID)(At follow-up visit (4-6 months from baseline))
  • International Physical Activity Questionnaire Short Form (IPAQ-S)(At follow-up visit (4-6 months from baseline))
  • Pittsburgh Sleep Quality Index (PSQI)(At follow-up visit (4-6 months from baseline))

研究者

申办方类型
Other
责任方
Sponsor

研究点 (4)

Loading locations...

相似试验